Arrayjet’s ArrayPlex platform selected by Immunome for use in its discovery of targeted cancer therapies Post author: Post published:March 18, 2024 Post category:uncategorized Immunome signs deal to use Arrayjet platform in its in-house screening operations. You Might Also Like Second-generation melanoma vaccine prolongs survival of patients with skin cancer March 29, 2024 New initiative aims to train pediatricians on early mental health detection October 24, 2024 Ownership-based text messages boost COVID booster uptake March 18, 2024